SAN DIEGO, CA--(Marketwired - April 02, 2014) - SpectraScience, Inc. (OTCQB: SCIE) announced today that the Company plans to file its late filings with the Securities and Exchange Commission in accordance with the schedule listed below:
--------------------------------------------------------------
Period Ending Expected Filing Date
--------------------------------------------------------------
10Q September 30, 2013 April 16, 2014
--------------------------------------------------------------
10K December 31, 2013 May 28, 2014
--------------------------------------------------------------
10Q March 31, 2014 June 16, 2014
--------------------------------------------------------------
In order to prevent inadvertent disclosure while catching up on filings, the next investor update call will be scheduled after the company is once again current in its submissions. It is expected the next business update conference call will be scheduled for late June.
About SpectraScience, Inc.
SpectraScience is a San Diego based medical device company that designs, develops, manufactures and markets light-based analysis systems capable of determining whether tissue is normal, pre-cancerous or cancerous without physically removing tissue from the body. The WavSTAT® Optical Biopsy System uses light to optically diagnose tissue and provide the physician with an immediate analysis. With approval for sale under the CE Mark for the European Union, the WavSTAT System is the first commercially available product that incorporates this innovative technology for clinical use.
Contacts:
Media and Investors:
SpectraScience, Inc.
Lowell Giffhorn
CFO
Phone: (858) 847-0200 x2019
Email: Email Contact
Help employers find you! Check out all the jobs and post your resume.
